A method for producing a maleimide compound having a group represented by the formula (a1), the method including condensing a primary amino group in a raw material compound having the primary amino group and dicarboxylic anhydride represented by the formula (a2) to generate a group represented by the formula (a3); and heating a compound having the group represented by the formula (a3), and converting the group represented by the formula (a3) into the group represented by the formula (a1).

A method for producing a maleimide compound having a group represented by the formula (a1), the method including condensing a primary amino group in a raw material compound having the primary amino group and dicarboxylic anhydride represented by the formula (a2) to generate a group represented by the formula (a3); and heating a compound having the group represented by the formula (a3), and converting the group represented by the formula (a3) into the group represented by the formula (a1).

Cysteine engineered monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules comprising one or more free cysteine amino acids are prepared by mutagenizing a nucleic acid sequence of a parent molecule and replacing one or more amino acid residues by cysteine to encode the cysteine engineered FN3 domain containing monospecific or bispecific molecules; expressing the cysteine engineered FN3 domain containing molecules; and recovering the cysteine engineered FN3 domain containing molecule. Isolated cysteine engineered monospecific or bispecific FN3 domain containing molecules may be covalently attached to a detection label or a drug moiety and used therapeutically.

A resistor grid system includes a resistor strip including multiple pins. The resistor grid system also includes an insulation board coupled to the resistor strip through the multiple pins and configured to provide a structural support. The insulation board is made of a composite material. The composite material includes a nitrogen-containing aromatic thermosetting polymeric resin and a filler.

A resistor grid system includes a resistor strip including multiple pins. The resistor grid system also includes an insulation board coupled to the resistor strip through the multiple pins and configured to provide a structural support. The insulation board is made of a composite material. The composite material includes a nitrogen-containing aromatic thermosetting polymeric resin and a filler.

Compounds having cytotoxic and/or anti-mitotic activity are disclosed. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed. Also disclosed are compositions having the structure: (T)-(L)-(D), wherein (T) is a targeting moiety, (L) is an optional linker, and (D) is a compound having cytotoxic and/or anti-mitotic activity.

Disclosed is a non-destructive universal method of functionalization of graphitic carbonaceous materials that enables their alignment, cross-linking, and effective integration into composite materials.

Disclosed is a non-destructive universal method of functionalization of graphitic carbonaceous materials that enables their alignment, cross-linking, and effective integration into composite materials.

Provided are fluorescent nanoparticles and their conjugates and methods of using the same for in vivo and in vitro diagnostics and other applications. In some embodiments, provided are fluorescent nanoparticles with high solid-state absolute quantum yield. In some embodiments, provided are methods of manufacturing such nanoparticles. Nanoparticles may comprise monomers, such as styrene, and fluorophores, such as AlEgen™ Bright Green.

Provided are a polymerizable compound having at least one monovalent group (A), a polymerizable composition containing the polymerizable compound, a liquid crystal composite prepared from the polymerizable composition, and a liquid crystal device having the polymerizable composition. ##STR00001## In monovalent group (A), R.sup.1 and R.sup.2 are independently hydrogen, halogen or alkyl having 1 to 20 carbons, and in the alkyl, at least one piece of —CH.sub.2— may be replaced by —O— or —S—, and at least one piece of —(CH.sub.2).sub.2— may be replaced by —CH═CH—, and in the groups, at least one hydrogen may be replaced by halogen.